Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

A month has gone by since the last earnings report for Nevro (NVRO). Shares have added about 15.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts ...

Analysts' ratings for Nevro (NYSE:NVRO) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below offers a condensed view of their recent ratings, showcasing ...

Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group ...

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...